−15.49 INR
−70.45 M INR
1.09 B INR
About Gkb Ophthalmics Limited
Sector
Industry
CEO
Krishna Gopal Gupta
Website
Headquarters
Mapusa
Founded
1981
ISIN
INE265D01015
FIGI
BBG000CTKY32
GKB Ophthalmics Ltd. is a holding company, which engages in the manufacture and sale of ophthalmic lenses made up of glass and plastic. Its products glass moulds bifocal moulds, include mineral, finished, semi-finished, and organic lenses. It operates through within India, and outside India geographical segments. The company was founded by Krishna Gopal Gupta on December 10, 1981 and is headquartered in Mapusa, India.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GKB is 73.98 INR — it has increased by 1.79% in the past 24 hours. Watch Gkb Ophthalmics Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Gkb Ophthalmics Limited stocks are traded under the ticker GKB.
GKB stock has fallen by −11.82% compared to the previous week, the month change is a −2.66% fall, over the last year Gkb Ophthalmics Limited has showed a −35.89% decrease.
GKB stock is 2.60% volatile and has beta coefficient of 0.55. Track Gkb Ophthalmics Limited stock price on the chart and check out the list of the most volatile stocks — is Gkb Ophthalmics Limited there?
Today Gkb Ophthalmics Limited has the market capitalization of 366.35 M, it has decreased by −4.58% over the last week.
Yes, you can track Gkb Ophthalmics Limited financials in yearly and quarterly reports right on TradingView.
GKB net income for the last quarter is −10.18 M INR, while the quarter before that showed −35.46 M INR of net income which accounts for 71.29% change. Track more Gkb Ophthalmics Limited financial stats to get the full picture.
No, GKB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 12, 2025, the company has 170 employees. See our rating of the largest employees — is Gkb Ophthalmics Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Gkb Ophthalmics Limited EBITDA is −30.17 M INR, and current EBITDA margin is −2.34%. See more stats in Gkb Ophthalmics Limited financial statements.
Like other stocks, GKB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gkb Ophthalmics Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Gkb Ophthalmics Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Gkb Ophthalmics Limited stock shows the strong sell signal. See more of Gkb Ophthalmics Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.